» Articles » PMID: 38700013

Sex Differences in Cardiovascular Outcomes in Patients With Kidney Failure

Abstract

Background: Cardiovascular disease is the leading cause of mortality in patients with kidney failure, and their risk of cardiovascular events is 10 to 20 times higher as compared with the general population.

Methods And Results: We evaluated 508 822 patients who initiated dialysis between January 1, 2005 and December 31, 2014 using the United States Renal Data System with linked Medicare claims. We determined hospitalization rates for cardiovascular events, defined by acute coronary syndrome, heart failure, and stroke. We examined the association of sex with outcome of cardiovascular events, cardiovascular death, and all-cause death using adjusted time-to-event models. The mean age was 70±12 years and 44.7% were women. The cardiovascular event rate was 232 per thousand person-years (95% CI, 231-233), with a higher rate in women than in men (248 per thousand person-years [95% CI, 247-250] versus 219 per thousand person-years [95% CI, 217-220]). Women had a 14% higher risk of cardiovascular events than men (hazard ratio [HR], 1.14 [95% CI, 1.13-1.16]). Women had a 16% higher risk of heart failure (HR, 1.16 [95% CI, 1.15-1.18]), a 31% higher risk of stroke (HR, 1.31 [95% CI, 1.28-1.34]), and no difference in risk of acute coronary syndrome (HR, 1.01 [95% CI, 0.99-1.03]). Women had a lower risk of cardiovascular death (HR, 0.89 [95% CI, 0.88-0.90]) and a lower risk of all-cause death than men (HR, 0.96 [95% CI, 0.95-0.97]).

Conclusions: Among patients undergoing dialysis, women have a higher risk of cardiovascular events of heart failure and stroke than men. Women have a lower adjusted risk of cardiovascular mortality and all-cause mortality.

Citing Articles

Effects of high-sensitivity C-reactive protein and left ventricular hypertrophy on cognitive function in hemodialysis patients.

Zhang Y, Gu Y, Zhang W, Li X, Xu L, Liu T Ren Fail. 2025; 47(1):2450522.

PMID: 39819254 PMC: 11749012. DOI: 10.1080/0886022X.2025.2450522.


Sex Differences in Cardiovascular-Kidney-Metabolic Syndrome: 30-Year US Trends and Mortality Risks-Brief Report.

Ji H, Sabanayagam C, Matsushita K, Cheng C, Rim T, Sheng B Arterioscler Thromb Vasc Biol. 2024; 45(1):157-161.

PMID: 39665141 PMC: 11729504. DOI: 10.1161/ATVBAHA.124.321629.


Sex-Specific Changes in Cardiac Function and Electrophysiology During Progression of Adenine-Induced Chronic Kidney Disease in Mice.

Dargam V, Sanchez A, Kolengaden A, Perez Y, Arias R, Valentin Cabrera A J Cardiovasc Dev Dis. 2024; 11(11).

PMID: 39590205 PMC: 11594452. DOI: 10.3390/jcdd11110362.

References
1.
Nakayama M, Sato T, Miyazaki M, Matsushima M, Sato H, Taguma Y . Increased risk of cardiovascular events and mortality among non-diabetic chronic kidney disease patients with hypertensive nephropathy: the Gonryo study. Hypertens Res. 2011; 34(10):1106-10. DOI: 10.1038/hr.2011.96. View

2.
Melloni C, Berger J, Wang T, Gunes F, Stebbins A, Pieper K . Representation of women in randomized clinical trials of cardiovascular disease prevention. Circ Cardiovasc Qual Outcomes. 2010; 3(2):135-42. DOI: 10.1161/CIRCOUTCOMES.110.868307. View

3.
Khera S, Kolte D, Gupta T, Subramanian K, Khanna N, Aronow W . Temporal Trends and Sex Differences in Revascularization and Outcomes of ST-Segment Elevation Myocardial Infarction in Younger Adults in the United States. J Am Coll Cardiol. 2015; 66(18):1961-1972. DOI: 10.1016/j.jacc.2015.08.865. View

4.
Regitz-Zagrosek V, Kararigas G . Mechanistic Pathways of Sex Differences in Cardiovascular Disease. Physiol Rev. 2016; 97(1):1-37. DOI: 10.1152/physrev.00021.2015. View

5.
Kramer H, Curhan G, Singh A . Permanent cessation of menses and postmenopausal hormone use in dialysis-dependent women: the HELP study. Am J Kidney Dis. 2003; 41(3):643-50. DOI: 10.1053/ajkd.2003.50126. View